What if one drug could delay menopause to promote longevity and overall health?

Menopause is the single biggest accelerant of unhealthy aging for women. There are currently no therapeutic interventions that directly address this health challenge. We aim to develop a groundbreaking therapeutic to improve and extend ovarian function throughout a woman’s lifespan by targeting a key regulator of ovarian function. The proposed studies will enable us to test various molecular approaches to develop a first-of-its-kind ovarian therapeutic, which will reach preclinical development milestones by the end of the funding period.

Topic 2: Prioritizing Ovarian Health